SKINCEUTICALS MICROPEEL 20 | Advanced Unbuffered Glycolic Acid Resurfacing & Chemoexfoliation Matrix

The SkinCeuticals Micropeel 20 is a medical-grade, high-performance in-office professional superficial chemical peeling treatment solution meticulously engineered to accelerate epidermal cellular turnover, eradicate stubborn hyperkeratotic accumulation, and optimize global cellular skin longevity. Calibrated strictly for clinical administration by licensed healthcare professionals, this intermediate-strength, low-viscosity liquid exfoliant deploys a highly active 20% concentration of pure unbuffered Glycolic Acid (Alpha-Hydroxy Acid). Operating as an intensive texturizing and corrective vehicle, its ultra-small molecular footprint dynamically breaks down the desmosomal bonds pinning dead, hyperpigmented keratinocytes to the stratum corneum—unveiling an exceptionally sleek, tonally uniform, and deeply revitalized skin canvas with minimal downtime.

PRODUCT SPECIFICATIONS & PACKAGING INCLUSIONS

• 1 x SkinCeuticals Micropeel 20 Professional Solution (2 fl oz / 60ml): A clinically calibrated unbuffered liquid chemoexfoliant packaged within a professional, high-integrity amber glass backbar bottle featuring an acid-resistant dropper assembly engineered to insulate the active free-acid matrix from premature atmospheric or light-driven degradation.

____________________________________________________________________________________________________________________________________________________________________________

KEY TECHNICAL SPECIFICATIONS & BENEFITS

• Deploys an Intermediate Unbuffered 20% Glycolic Acid Payload operating at a highly active, low-pH baseline to maximize free-acid bio-availability and optimize desquamation depth.

• Harnesses a Low-Viscosity, Ultra-Small Molecular Structure that effortlessly floods the epidermal sheets to rapidly sweep away thick, sallow dead cell accumulation.

• Significantly Diminishes Structural Fine Lines and Early Mechanical Wrinkles by forcing rapid cellular renewal and stimulating the biosynthetic pathways of the underlying dermal matrix.

• Eradicates Stubborn Superficial Pigmentary Staining, accelerating the removal of heavily melanized surface layers to clear post-inflammatory hyperpigmentation (PIH) and sun spots.

• Visibly Clears and Compresses Extruded Pore Outlines, lifting the hardened keratinous plugs that structurally stretch, expand, and distort follicular walls.

• Functions as an Absolute Penetration Primer, removing the dense cellular shield to radically amplify the transdermal migration and bio-availability of subsequent clinical active topicals.

____________________________________________________________________________________________________________________________________________________________________________

PRIMARY INDICATIONS & USE CASES

• Normal, dry, oily, combination, or lackluster skin landscapes exhibiting early to moderate signs of photoaging, micro-textural roughness, and localized environmental staining.

• Skin profiles that have successfully completed a Micropeel 15 cycle and require an escalated free-acid percentage to drive deeper, more profound epidermal remodeling.

• Complexions marred by persistent sallow dullness, uneven light-reflection, and dark spots left behind by healed acne lesions.

• In-office clinical administration safe for comprehensive deployment across universal Fitzpatrick phototypes (I-VI) with mandatory professional pre-conditioning.

____________________________________________________________________________________________________________________________________________________________________________

FREQUENTLY ASKED QUESTIONS

Q: What makes the unbuffered 20% Glycolic Acid inside Micropeel 20 more effective than higher-percentage buffered retail peels?

A: The clinical efficacy of an alpha-hydroxy acid peel is governed by its free-acid availability and pH baseline, not merely the raw percentage stated on the packaging. Many consumer retail chemical peels are heavily buffered, which raises the formula's pH and neutralizes the active acid molecules, rendering them passive. SkinCeuticals Micropeel 20 features a completely unbuffered liquid platform. This optimization ensures that the entire 20% glycolic payload remains fully bio-available to immediately target surface hyperkeratosis upon contact, delivering a predictable cellular renewal that easily outperforms higher-percentage, buffered alternatives.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Q: How does Micropeel 20 position itself within the broader SkinCeuticals professional peeling hierarchy?

A: Micropeel 20 serves as the critical intermediate step in the professional unbuffered glycolic acid peeling series (progressing from Micropeel 15 to 20, and finally Micropeel 30). While Micropeel 15 is optimized for unconditioned or sensitive skin matrices to establish baseline acid tolerance, Micropeel 20 steps up the intensity to target more deep-seated photoaging, rougher texture, and moderate hyperpigmentation. It allows the clinician to safely escalate cellular turnover and dermal stimulation without shocking the skin barrier, creating a progressive pathway toward the maximum-strength Micropeel 30.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Q: What is the expected skin-shedding cascade and clinical downtime following a Micropeel 20 session?

A: Because Micropeel 20 targets the upper layers of the epidermis, it is classified as a controlled superficial treatment with exceptionally low downtime. Patients will experience mild to moderate, transient erythema (redness) and localized warmth for 2 to 24 hours post-procedure. Rather than shedding in heavy, unmanageable sheets, the skin will undergo a manageable micro-flaking or dry powder-like peeling phase starting around day 2 or 3. This shedding cascade typically self-neutralizes cleanly by day 5 to 7, revealing a completely smooth, bright, and luminous skin canvas.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Q: Is Micropeel 20 safe to deploy on darker Fitzpatrick phototypes (V-VI) without inducing rebound dark spots?

A: Yes, exceptionally well, provided strict clinical pre-conditioning protocols are enforced. Darker skin profiles possess highly active melanocytes that can easily overreact to erratic or aggressive chemical trauma, leading to post-inflammatory hyperpigmentation (PIH). The 20% concentration provides a highly controlled, progressive treatment depth that gently resurfaces the tissue without shocking underlying pigment cells. However, patients with Fitzpatrick phototypes V and VI must pre-condition their skin barrier for 2 to 4 weeks prior to the peel with a daily SkinCeuticals antioxidant and pigment regulator to fully sedate melanocytes.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Q: What is the mathematically precise application and neutralization protocol for this clinical peel?

A: This solution must be applied strictly according to professional clinical guidelines. Following a thorough dual-cleansing and degreasing step, the clinician saturates a professional gauze pad or cotton swab with the Micropeel 20 liquid. The solution is applied quickly and evenly across the facial matrix, avoiding the immediate eye contours and lip margins. The solution must be timed precisely and left undisturbed for exactly 2 to 5 minutes, depending on the patient's structural skin thickness and neuro-sensory feedback. The peel is not self-limiting; therefore, it must be completely deactivated using a dedicated sodium bicarbonate neutralizer or copious amounts of cool water until all tingling sensations cease entirely. Conclude with a recovery balm and a 100% mineral sunscreen.